Bruno Canard, Étienne Decroly: Wuhan, ein neues Hiroshima? First published in Manière de voir No. 179 (October / November 2021), translation: Bernd Schrader. The authors are research directors of the Centre national de la recherche scientifique (CNRS), Laboratory of Architecture and Function of Biological Macromolecules, University of Aix-Marseille. The exact origin of the Covid-19 pandemic remains unknown, no solid evidence allows to validate the hypotheses. Many scientists demand an independent investigation, freed from the resistance of the Chinese authorities. Because the negligence observed in Wuhan raises questions about the genetic manipulations carried out in this laboratory, as in those of […]
Monthly archives: October 2021
3 posts
Arjun Puranik, Patrick J. Lenehan, Eli Silvert, Michiel J.M. Niesen, Juan Corchado-Garcia, John C. O’Horo, Abinash Virk, Melanie D. Swift, John Halamka, Andrew D. Badley, A.J. Venkatakrishnan, Venky Soundararajan: Comparison of two highly-effective mRNA vaccines for COVID-19 during periods of Alpha and Delta variant prevalence, in: medRxiv (August 21, 2021), https://doi.org/10.1101/2021.08.06.21261707. Although clinical trials and real-world studies have affirmed the effectiveness and safety of the FDA-authorized COVID-19 vaccines, reports of breakthrough infections and persistent emergence of new variants highlight the need to vigilantly monitor the effectiveness of these vaccines.
Koen B. Pouwels, Emma Pritchard, Philippa C. Matthews, Nicole Stoesser, David W. Eyre, Karina-Doris Vihta, Thomas House, Jodie Hay, John I. Bell, John N. Newton, Jeremy Farrar, Derrick Crook, Duncan Cook, Emma Rourke, Ruth Studley, Tim Peto, Ian Diamond, A. Sarah Walker and the COVID-19 Infection Survey Team: Impact of Delta on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK , in: medRxiv (August 24, 2021), https://doi.org/10.1101/2021.08.18.21262237. The effectiveness of BNT162b2, ChAdOx1, and mRNA-1273 vaccines against new SARS-CoV-2 infections requires continuous re-evaluation, given the increasingly dominant Delta variant. The authors investigated the effectiveness of the vaccines in […]